Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell × Blood Component Removal × 90 days × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 1 Solid Tumor 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasms 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Kidney Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Blast Crisis 1

Interventions

Cyclophosphamide 16 Rituximab 13 fludarabine 10 pirtobrutinib 7 Specimen Handling 7 Magnetic Resonance Spectroscopy 7 glofitamab 5 Doxorubicin 5 venetoclax 4 fludarabine phosphate 4 Vincristine 4 Prednisone 4 Leukapheresis 4 Biopsy 4 zanubrutinib 3 polatuzumab vedotin 3 pembrolizumab 3 obinutuzumab 3 Lenalidomide 3 Etoposide 3 Dexamethasone 3 Bendamustine Hydrochloride 3 tazemetostat 2 tafasitamab 2 axicabtagene ciloleucel 2 acalabrutinib 2 Gemcitabine 2 Cytarabine 2 Cisplatin 2 Calcium Dobesilate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡